Reference:
1. Richman DD WR, Hayden FG. Clinical virology . 4th ed. Washington: ASM Press, 2016.
2. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348 (20):1967-76 doi: 10.1056/NEJMoa030747[published Online First: Epub Date]|.
3. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348 (20):1953-66 doi: 10.1056/NEJMoa030781[published Online First: Epub Date]|.
4. Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003;362 (9380):263-70 doi: 10.1016/S0140-6736(03)13967-0[published Online First: Epub Date]|.
5. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367 (19):1814-20 doi: 10.1056/NEJMoa1211721[published Online First: Epub Date]|.
6. de Groot RJ, Baker SC, Baric RS, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 2013;87 (14):7790-2 doi: 10.1128/JVI.01244-13[published Online First: Epub Date]|.
7. 高艳梅, 魏芳. 细胞凋亡抑制蛋白-1在宫颈癌及宫颈癌化疗耐药方面的研究进展. 中华临床医师杂志(电子版) (4)
8. PD M, S S, CL D. Assembling the building blocks: structure and function of inhibitor of apoptosis proteins. Cell death and differentiation 2010;17 (1):46-53 doi: 10.1038/cdd.2009.45[published Online First: Epub Date]|.
9. Lacasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer.17 (25):3247-59
10. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-Linked IAP is a direct inhibitor of cell-death proteases. Nature 1997;388 (6639):300-04
11. Chai J, Du C, Wu JW, Kyin S, Shi Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 2000;406 (6798):855-62
12. Yu W-BT, Guang-Da ;Zhang, Li ; Corlett, Richard T. . Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2) using whole genomic data.
13. Coronavirus disease (COVID-19) Situation dashboard: WHO., 2020.
14. China NHCotPsRo. Diagnosis and treatment of pneumonia caused by novel coronavirus infection (Trial version 5), 2020.
15. China NHCotPsRo. Diagnosis and treatment of severe and critical cases of new coronavirus pneumonia (Trial version 2), 2020.
16. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395 (10223):514-23 doi: 10.1016/S0140-6736(20)30154-9[published Online First: Epub Date]|.
17. Notice of leading group for prevention and control of pneumonia caused by new coronavirus infection in wenzhou city (No.1). In: city Lgfpacopcbnciiw, ed. Wenzhou: Wenzhou daily nespaper, 2020.
18. Notice of leading group for prevention and control of pneumonia caused by new coronavirus infection in wenzhou city (No.6). In: city Lgfpacopcbnciiw, ed. Wenzhou: Wenzhou daily nespaper, 2020.
19. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020 doi: 10.1001/jama.2020.1585[published Online First: Epub Date]|.
20. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395 (10223):507-13 doi: 10.1016/S0140-6736(20)30211-7[published Online First: Epub Date]|.
21. Ki M, nCo VT. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Republic of Korea. Epidemiol Health 2020:e2020007 doi: 10.4178/epih.e2020007[published Online First: Epub Date]|.
22. Wang D, Ju XL, Xie F, et al. [Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China]. Zhonghua Er Ke Za Zhi 2020;58 (4):E011 doi: 10.3760/cma.j.cn112140-20200225-00138[published Online First: Epub Date]|.
23. Xie C, Jiang L, Huang G, et al. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. Int J Infect Dis 2020 doi: 10.1016/j.ijid.2020.02.050[published Online First: Epub Date]|.
24. Xu K, Cai H, Shen Y, et al. [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2020;49 (1):0
25. To KK, Tsang OT, Chik-Yan Yip C, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020 doi: 10.1093/cid/ciaa149[published Online First: Epub Date]|.
26. Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. J Infect 2020 doi: 10.1016/j.jinf.2020.02.016[published Online First: Epub Date]|.
27. Xu YH, Dong JH, An WM, et al. Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2. J Infect 2020 doi: 10.1016/j.jinf.2020.02.017[published Online First: Epub Date]|.
28. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020 doi: 10.1038/s41586-020-2012-7[published Online First: Epub Date]|.
29. mRNA Expression by UniProt/SwissProt for ACE2 Gene: GeneCards, 2020.